Emerging therapies for endometriosis


Like Comment
Related Content

VOLUME 115, ISSUE 2, P317-318


Hugh S. Taylor, M.D.


Reflections on "Relugolix, an oral GnRH receptor antagonist, reduces endometriosis-associated pain in a dose-response manner: a randomized, double-blind, placebo-controlled study" by Osuga et al.

Read the full text here. 

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders.